Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07056049

The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery

Efficacy of High-dosage, High-intensity Rehabilitation Program on the Motor Recovery After Stroke in Subacute Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Adi Negev-Nahalat Eran · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Intervention abstract Background: Stroke is the leading cause of long-term disability, and the second leading cause of death in the western world. Most stroke survivors will suffer from motor and cognitive disturbances for the rest of their life, which negatively affects their normal daily life. Despite the decline in stroke-related mortality over the past decades, the outcome of rehabilitation programs does not improve, and is predictable regardless of the program used. Still, several human and animal studies show that high capacity of training in the early stages post stroke improve motor recovery. This notion is far from being well established. Aim: Studying the effect of high-dosage, high-intensity training program in the subacute period on upper extremity motor recovery. Population: Stroke survivors. Study duration: 6 months. Study protocol: Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks. They will be monitored pre and post training, and 6 months post-stroke. Outcome measures will include clinical, kinematic and adherence measures (see complete list in the protocol).

Conditions

Interventions

TypeNameDescription
BEHAVIORALHigh dosage, high intensity motor rehabilitationParticipants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks.

Timeline

Start date
2025-07-13
Primary completion
2027-01-15
Completion
2027-07-15
First posted
2025-07-09
Last updated
2025-07-17

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT07056049. Inclusion in this directory is not an endorsement.